Rhea N. Coler

Center for Global Infectious Disease Research, Seattle Children's Research Institute

Affiliated withSeattle Children's Research Institute University of Washington School of Medicine University of Washington

Research Area

Immunology and Infection

Biography

Rhea N. Coler has not added Biography.
If you are Rhea N. Coler and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. The New England journal of medicine\| PubMed ID: 32663912	2020
Diagnostics and the neglected tropical diseases roadmap: setting the agenda for 2030. Transactions of the Royal Society of Tropical Medicine and Hygiene\| PubMed ID: 33169166	2021
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model. PloS one\| PubMed ID: 33705411	2021
Subunit vaccine protects against a clinical isolate of Mycobacterium avium in wild type and immunocompromised mouse models. Scientific reports\| PubMed ID: 33907221	2021
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples. bioRxiv : the preprint server for biology\| PubMed ID: 34230930	2021
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples. Journal of immunological methods\| PubMed ID: 34599915	2021
Homologous and Heterologous Covid-19 Booster Vaccinations. The New England journal of medicine\| PubMed ID: 35081293	2022
It Takes a Village: The Multifaceted Immune Response to Infection and Vaccine-Induced Immunity. Frontiers in immunology\| PubMed ID: 35359957	2022
Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against infection but is ineffective as an adjunct to antibiotic tr... Virulence\| PubMed ID: 35499090	2022
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant. Cell reports. Medicine\| PubMed ID: 35798000	2022
: It's Complex. Microorganisms\| PubMed ID: 35889173	2022
Therapeutic efficacy against using ID93 and liposomal adjuvant formulations. Frontiers in microbiology\| PubMed ID: 36090093	2022
Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination. medRxiv : the preprint server for health sciences\| PubMed ID: 36203549	2022
Characterizing in vivo loss of virulence of an HN878 Mycobacterium tuberculosis isolate from a genetic duplication event. Tuberculosis (Edinburgh, Scotland)\| PubMed ID: 36375278	2022
Adjuvants influence the maturation of VRC01-like antibodies during immunization. iScience\| PubMed ID: 36405776	2022
Editorial: Beyond Th1: Novel concepts in tuberculosis vaccine immunology. Frontiers in immunology\| PubMed ID: 36505491	2022
Immunogenicity and protection against Mycobacterium avium with a heterologous RNA prime and protein boost vaccine regimen. Tuberculosis (Edinburgh, Scotland)\| PubMed ID: 36586154	2023
Spike-specific T cells are enriched in breastmilk following SARS-CoV-2 mRNA vaccination. Mucosal immunology\| PubMed ID: 36642379	2023
Tuberculosis vaccines update: Is an RNA-based vaccine feasible for tuberculosis? International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases\| PubMed ID: 36963657	2023
SARS-CoV-2 infection and immune responses. AIMS microbiology\| PubMed ID: 37091818	2023
Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. Infectious diseases and therapy\| PubMed ID: 37166567	2023
Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration. Pharmaceuticals (Basel, Switzerland)\| PubMed ID: 37242512	2023
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants. NPJ vaccines\| PubMed ID: 37433788	2023
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn. Vaccine\| PubMed ID: 37451878	2023
Protective interplay: diminishes SARS-CoV-2 severity through innate immune priming. Frontiers in immunology\| PubMed ID: 38966641	2024
Antibodies as key mediators of protection against . Frontiers in immunology\| PubMed ID: 39286260	2024
The chosen few: isolates for IMPAc-TB. Frontiers in immunology\| PubMed ID: 39530100	2024
Comparative study on the virulence of mycobacteriophages. bioRxiv : the preprint server for biology\| PubMed ID: 39554140	2024
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependent. mSphere\| PubMed ID: 39651886	2025
Understanding the development of tuberculous granulomas: insights into host protection and pathogenesis, a review in humans and animals. Frontiers in immunology\| PubMed ID: 39717773	2024
Evaluation of host immune responses to Mycobacteriophage Fionnbharth by route of delivery. Virology journal\| PubMed ID: 39833928	2025
Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniques. npj antimicrobials and resistance\| PubMed ID: 39843983	2024
Recombinase-based amplification coupled with lateral flow chromatography for the specific and sensitive detection and identification of in cutaneous leishmaniasis patients. Frontiers in microbiology\| PubMed ID: 39931278	2024
The Sm14+GLA-SE Recombinant Vaccine Against and in Adults and School Children: Phase II Clinical Trials in West Africa. Vaccines\| PubMed ID: 40266229	2025
Characterizing TLR4 agonist EmT4™ as an anti-Mycobacterium tuberculosis vaccine adjuvant. ImmunoHorizons\| PubMed ID: 40285479	2025
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine. The Journal of infectious diseases\| PubMed ID: 40298376	2025
Comparative study on the virulence of mycobacteriophages. Journal of virology\| PubMed ID: 40396760	2025
Development and Concordance of Binding and Neutralizing Assays to Determine SARS-CoV-2 Antibody Activity in Human Milk. Pathogens & immunity\| PubMed ID: 40475854	2025
Infant Antibodies After Maternal COVID-19 Vaccination During Pregnancy or Postpartum. Pediatrics\| PubMed ID: 40550509	2025